InsidersTradesSigma
Total declarations
Companies
▲ Purchases (0 ops.)
▼ Sales (2 ops.)
Insider track record
ExecutiveDisclosed buys
0
Disclosed sells
2
T+90 hit rate
25%
T+90 mean return
-6.2%
Across 12 buy signals with a settled T+90 return. Return basis: close on the day after publication.
Signal history
Discover the detailed record of transactions filed by GALA RENEE D, Director. Director active across 2 companies, notably DEXCOM INC. Cumulatively, 20 disclosures have been recorded. Breakdown: 0 buy · 2 sells. Total volume traded: €1.1m. Activity tracked since 3 March 2022. The latest transaction was filed on 28 May 2026 (Attribution). Regulator: SEC (Form 4). The full history is openly available.
Declarations20 total
5,605 shares0Common StockSEC:0001093557-26-000116:0
1,161 shares0Common StockSEC:0001093557-25-000224
1,161 shares0Common StockSEC:0001093557-25-000224:0
5,074 shares0Common StockSEC:0001093557-25-000154:0
5,720 shares0Common StockSEC:0001093557-25-000055:0
5,704 shares@ US$138.9525.3% of flowOrdinary SharesSEC:0001765581-25-000025:0
23,111 shares0Ordinary SharesSEC:0001765581-25-000014:0
7,741 shares0Ordinary SharesSEC:0001805688-25-000009:0
80 shares@ US$123.450.3% of flowOrdinary SharesSEC:0001765581-24-000094:0
1,736 shares@ US$115.216.3% of flowOrdinary SharesSEC:0001765581-24-000040:0
3,622 shares@ US$117.5313.3% of flowOrdinary SharesSEC:0001765581-24-000036:0
19,916 shares0Ordinary SharesSEC:0001765581-24-000015:0
7,079 shares0Ordinary SharesSEC:0001784606-24-000006:0
772 shares0Ordinary SharesSEC:0001765581-23-000106:0
6,000 shares@ US$131.745724.9% of flowOrdinary SharesSEC:0001765581-23-000042:0
1,807 shares@ US$145.788.2% of flowOrdinary SharesSEC:0001765581-23-000040:0
12,784 shares0Ordinary SharesSEC:0001765581-23-000024:0
2,635 shares@ US$160.0013.5% of flowOrdinary SharesSEC:0001765581-22-000143:0
1,633 shares@ US$162.880.0017% mcap100.0% of flowOrdinary SharesSEC:0001765581-22-000038:0
11,730 shares0Ordinary SharesSEC:0001765581-22-000017:0
20 of 20 declarations
About GALA RENEE D
Renee D. Gala serves as Director, Executive Vice President, and Chief Financial Officer at Dexcom Inc. and Jazz Pharmaceuticals plc. She is responsible for the financial management of these companies, overseeing financial and strategic operations. Her expertise in finance and accounting is crucial for informed decision-making within both organizations.
